WinstonWınston
Back
Labcorp Holdings logo

Labcorp Holdings

LH
51
Medical - Diagnostics & Research · Healthcare
Also trades as: 0JSY.L
Price
$336.34
+3.53 (+1.06%)
Market Cap
$27.58B
Exchange
New York Stock Exchange
Winston Score
51
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Strong
Cash Flow
Strong
Stability
Good
Valuation
Strong
Dividends
Weak

Share count falling — buybacks

14.1% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 97.5M (2021) → 83.8M (2025)

Winston Score History

The full picture

Labcorp is one of the largest medical testing companies in the United States. It collects blood, urine, and tissue samples from patients and runs laboratory tests that help doctors diagnose diseases, monitor health conditions, and guide treatment decisions. The company serves patients, hospitals, physician offices, and pharmaceutical companies across a wide range of testing needs, from routine blood work to complex genetic analysis.

Labcorp makes money by charging fees for each test it performs, with payments coming from insurance companies, government programs like Medicare and Medicaid, and patients directly. It operates thousands of patient service centers and labs primarily across the U.S., with some international presence, and processes hundreds of millions of tests each year. Its scale and established network of collection sites give it a cost advantage over smaller competitors. The main risk the company faces is ongoing pressure from insurers and government payers to lower reimbursement rates, which can squeeze profit margins over time.

Politician Trades

14 trades / 12mo

8 Congressional buys and 6 sells on LH in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+28.0% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

0.4%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$281M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Labcorp Holdings is growing revenue at 6% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
29.8%
Modest — 29.8% gross margin
Profit after running costs
Operating Margin
12.1%
Healthy — 12.1% operating margin
Return on the money invested
ROCE
11.2%
Below par — 11.2% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+6.4%
Slow sales growth (+6.4% YoY)
Profit growth
EPS YoY
+33.2%
Earnings growing fast (+33.2% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
163%
Turns 163% of profit into real cash
Spare cash per sale
FCF Margin
8.1%
Modest free cash flow (8.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.68
Moderate — manageable debt (0.68)
Covers its interest
Interest Cover
7.12x
Adequate interest coverage (7.1x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
27.6x
Growth-priced — P/E 27.6

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+13.2
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (27.6 → 14.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.93%
Small dividend — 0.93% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial